ARWRArrowhead Pharmaceuticals, Inc.
$58.02+49% 1Y
$58.02
$36.8152 weeks$89.61
Is the price fair?
What ARWR's price assumes
Arrowhead Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 17.5× revenue.
17.5
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 25.1
Price / book · as of 2026-Q2
- EV / sales
- 15.3
EV / sales
Details›
- Price / bookas of 2026-Q2
- 25.1
- EV / EBIToperating margin −34%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 15.3
- Market capitalisation141.3 million shares, counted Jul 30, 2026
- $8.19B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.